Concise, Actionable Medical & Drug Information Resources
PEPID’s content is specifically designed for you
Please Choose Your Role or Profession
PRACTICING
PROFESSIONAL
HOSPITAL & HEALTH
SYSTEMS
INSTITUTION OR
GROUP
STUDENT OR
RESIDENT
Everything you need in one powerful app
Established in 1994, PEPID’s complete catalog of healthcare information solutions supports thousands of institutions across the globe. Extensive, intuitive, and easily integrated – PEPID’s clinical and drug databases strengthen critical decision-making at any point-of-care and beyond.WATCH OVERVIEW VIDEO
As a training physician, Dr. Rosenbloom’s lab coat pockets overflowed with his handwritten, detailed medical and drug reference notes he realized it was invaluable in making diagnostic and therapeutic decisions. When the first personal digital assistants were released, Dr. Rosenbloom copied all of his notes into his handheld computer’s phone book.
Colleagues encouraged Dr. Rosenbloom to expand his electronic notes into a portable, comprehensive medical and drug resource for more widespread use. As a result, in 1994, Dr. Rosenbloom developed the first version of PEPID with an advisory board of more than 35 board-certified physicians and pharmacologists.
Trusted Content Partners. Frequent Updates. Peer-Reviewed.
Omicron Variant: BA.2 Sublineage By Hannah Morpurgo and Julia Schurr According to the World Health Organization, by February 19, 2022, BA.2 had been detected in 74 countries and 47 US states. BA.2 is a subvariant of Omicron which, according to studies from the UK and...
Read More
Emergency Use Authorization The CDC now recommends the Pfizer-BioNTech COVID-19 vaccine (BNT162b2) for children ages 5-11 years after the FDA’s EUA approval and support from the Advisory Committee on Immunization Practices (ACIP). The authorization is based on data...
Read More
Emergency Use Authorization The CDC now recommends the Pfizer-BioNTech COVID-19 vaccine (BNT162b2) for children ages 5-11 years after the FDA’s EUA approval and support from the Advisory Committee on Immunization Practices (ACIP). The authorization is based on data...
Read More
Emergency Use Authorization The CDC now recommends the Pfizer-BioNTech COVID-19 vaccine (BNT162b2) for children ages 5-11 years after the FDA’s EUA approval and support from the Advisory Committee on Immunization Practices (ACIP). The authorization is based on data...
Read More
or call us 888.321.7828